Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

New cytokine-targeted therapies show promise for treating alopecia areata.

Rosemary extracts with carnosic acid and carnosol can reduce the harmfulness of Staphylococcus aureus without stopping its growth.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.